Literature DB >> 10499080

Genetic epidemiology of host predisposition microfilaraemia in human loiasis.

A Garcia1, L Abel, M Cot, P Richard, S Ranque, J Feingold, F Demenais, M Boussinesq, J P Chippaux.   

Abstract

Evidence is accumulating from experimental and human studies that genetic factors are involved both in the control of infectious diseases and in the regulation of infection levels and clinical presentation. So far few studies have investigated the role of these genetic factors in human infection by the filarial parasite Loa loa. We present a segregation analysis on 74 nuclear families who live in the tropical rainforest of southern Cameroun and are exposed to homogeneous loiasis transmission. The results indicate that there is a genetic predisposition to be microfilaraemic and that predisposed subjects might be genetically unable to mount an efficient immune response against loiasis antigens. This individual susceptibility could explain at least in part why the prevalence of infection (microfilaraemic individuals) does not usually exceed 30% of the exposed population in hyperendemic regions. Further genetic studies, based on linkage analysis using both familial information and genetic markers, will help to identify the nature of the genetic factors predisposing to microfilaraemia.

Entities:  

Mesh:

Year:  1999        PMID: 10499080     DOI: 10.1046/j.1365-3156.1999.00442.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  6 in total

1.  Case report: Loiasis with peripheral nerve involvement and spleen lesions.

Authors:  Federico Gobbi; Michel Boussinesq; Marta Mascarello; Andrea Angheben; Maria Gobbo; Andrea Rossanese; Manuel Corachán; Zeno Bisoffi
Journal:  Am J Trop Med Hyg       Date:  2011-05       Impact factor: 2.345

2.  Epidemiology of concomitant infection due to Loa loa and Mansonella perstans in Gabon.

Authors:  Jean Paul Akue; Dieudonné Nkoghe; Cindy Padilla; Ghislain Moussavou; Hubert Moukana; Roger Antoine Mbou; Benjamin Ollomo; Eric Maurice Leroy
Journal:  PLoS Negl Trop Dis       Date:  2011-10-11

3.  Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients.

Authors:  Charles D Mackenzie; Timothy G Geary; John A Gerlach
Journal:  Filaria J       Date:  2003-10-24

4.  Positivity of Antigen Tests Used for Diagnosis of Lymphatic Filariasis in Individuals Without Wuchereria bancrofti Infection But with High Loa loa Microfilaremia.

Authors:  Sébastien D Pion; Céline Montavon; Cédric B Chesnais; Joseph Kamgno; Samuel Wanji; Amy D Klion; Thomas B Nutman; Michel Boussinesq
Journal:  Am J Trop Med Hyg       Date:  2016-10-10       Impact factor: 2.345

5.  Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study.

Authors:  Sébastien Ds Pion; Hugues Nana-Djeunga; Yannick Niamsi-Emalio; Cédric B Chesnais; Hugo Deléglise; Charles Mackenzie; Wilma Stolk; Daniel A Fletcher; Amy D Klion; Thomas B Nutman; Michel Boussinesq; Joseph Kamgno
Journal:  Lancet Infect Dis       Date:  2019-10-31       Impact factor: 25.071

6.  Molecular Epidemiology of Blood-Borne Human Parasites in a Loa loa-, Mansonella perstans-, and Plasmodium falciparum-Endemic Region of Cameroon.

Authors:  Papa M Drame; Céline Montavon; Sébastien D Pion; Joseph Kubofcik; Michael P Fay; Thomas B Nutman
Journal:  Am J Trop Med Hyg       Date:  2016-04-04       Impact factor: 2.345

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.